Covered Stocks

Dennis Ding

Work

Analyst Dennis Ding works at JEFFERIES and is focused on the Healthcare sector with 16 price targets and ratings documented since 2021 spanning on 4 stocks. Analyst's average stock valuation to be materialised ratio is 25% with an average time for price targets to be met of 10.25 days.

Most recent stock forecast was given on NGM, NGM Biopharmaceuticals, Inc at 17-Oct-2022.

Dennis Ding best performing recommendations are on ROIV.
The best stock recommendation documented was for ROIV at 11/1/2021. The price target of $10 was fulfilled within 38 days with a profit of $2.19 (28.04%) receiving and performance score of 7.38.

Average potential price target upside

  • of $2.23 (28.62%) on ROIV.
ABUS NGM PRDS ROIV

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

5

$2.07 (70.65%)

11 months 26 days ago

0/2 (0%)

$1.72 (56.20%)

Buy

5

$2.07 (70.65%)

5

1 years 1 months 27 days ago

3/5 (60%)

$1.02 (33.22%)

59

Buy

7

$4.07 (138.91%)

7

1 years 7 months 1 days ago

0/4 (0%)

$4.08 (92.75%)

Buy

7

$4.07 (138.91%)

8

1 years 10 months 19 days ago

1/4 (25%)

$3.58 (92.40%)

196

Buy

6

$3.07 (104.78%)

5

1 years 10 months 21 days ago

3/6 (50%)

$2.61 (50.12%)

28

Show more analysts
ABUS NGM PRDS ROIV